Fabrication and assessment of ethosomes for effective transdermal delivery of loxoprofen | ||
| Iranian Journal of Basic Medical Sciences | ||
| مقاله 5، دوره 28، شماره 6، شهریور 2025، صفحه 728-738 اصل مقاله (713.36 K) | ||
| نوع مقاله: Original Article | ||
| شناسه دیجیتال (DOI): 10.22038/ijbms.2025.84183.18206 | ||
| نویسندگان | ||
| Sarah Jabbar Abd Alhur1، 2؛ Hasanain Shakir Mahmood* 2، 3، 4 | ||
| 1Department of Pharmaceutics, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq | ||
| 2Department of Pharmaceutics, College of Pharmacy, University of Kerbala, Kerbala, Iraq | ||
| 3Department of Pharmaceutics, College of Pharmacy, University of Alkafeel, Najaf, Iraq | ||
| 4ARCPMS, University of Alkafeel, Najaf, Iraq | ||
| چکیده | ||
| Objective(s): To formulate and evaluate ethosomes for the transdermal delivery of loxoprofen, a potent non-steroidal anti-inflammatory drug (NSAID). Materials and Methods: Fifteen ethosomal formulations were created via thin-film hydration and probe sonication techniques, with variations in the amounts of egg yolk lecithin, ethanol, cholesterol (CHOL), Tween 80 (TW80), and propylene glycol (PG). The formulations were assessed for their particle size (PS), zeta potential (ZP), polydispersity index (PDI), pH, and entrapment efficiency (EE). Field scanning electron microscopy (FSEM) was utilized to evaluate their morphology. The in vitro drug release and ex vivo permeability of the ethosomal formulations were evaluated against those in a hydroethanolic drug solution. Results: The formulation labeled F14, comprising 1% loxoprofen, 1% egg yolk lecithin, 30% ethanol, 5% propylene glycol, and phosphate-buffered saline (PBS) up to 25 ml, was recognized as an optimized ethosomal formulation. These ethosomes demonstrated an average size of 164.2±19 nm, a PDI of 0.280±0.028, a ZP of +45.1±4.5 mV, and an EE of 96.8±0.43%. In vitro and ex vivo tests demonstrated that the ethosomal formulation (F14) showed superior drug release and penetration rates compared to a conventional hydroalcoholic solution. The differential scanning calorimetry (DSC) study showed that loxoprofen was completely trapped within ethosomes. On the other hand, the Fourier transform infrared (FTIR) study confirmed that the drug and the additives did not interact. Conclusion: The current study revealed that loxoprofen can be effectively delivered transdermally via the ethosomal system. | ||
| کلیدواژهها | ||
| Ethosomes؛ Loxoprofen؛ Nanocarriers؛ NSAID؛ TDDS | ||
| مراجع | ||
|
1. Hui M, Quan P, Yang Y, Fang L. The effect of ion-pair formation combined with penetration enhancers on the skin permeation of loxoprofen. Drug Deliv 2016; 23: 1550-1557. 2. Ryu S-R, Shin S-C. Controlled transdermal delivery of loxoprofen from an ethylene-vinyl acetate matrix. J Pharm Invest 2011; 41: 347-354. 3. Jeong WY, Kwon M, Choi HE, Kim KS. Recent advances in transdermal drug delivery systems: A review. Biomater Res 2021;25: 24-39. 4. Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 2000; 65: 403-418. 5. Bom S, Ribeiro HM, Marto J. Sustainability calculator: A tool to assess sustainability in cosmetic products. Sustainability 2020; 12: 1437. 6. Chauhan N, Vasava P, Khan SL, Siddiqui FA, Islam F, Chopra H, et al. Ethosomes: A novel drug carrier. Ann Med Surg (Lond) 2022;82:104595-104599. 7. Arora D, Nanda S. Quality by design driven development of resveratrol loaded ethosomal hydrogel for improved dermatological benefits via enhanced skin permeation and retention. Int J Pharm 2019; 567: 118448. 8. Riccardi D, Baldino L, Reverchon E. Liposomes, transfersomes and niosomes: Production methods and their applications in the vaccinal field. J Transl Med 2024; 22: 339-352. 9. Abdulbaqi IM, Darwis Y, Khan NAK, Assi RA, Khan AA. Ethosomal nanocarriers: The impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials. Int J Nanomedicine 2016; 11: 2279-2304. 10. Limsuwan T, Amnuaikit T. Development of ethosomes containing mycophenolic acid. Procedia Chem 2012; 4: 328-35. 11. Zhang M, Zhuang X, Li S, Wang Y, Zhang X, Li J, et al. Designed fabrication of phloretin-loaded propylene glycol binary ethosomes: Stability, skin permeability and antioxidant activity. Molecules 2023; 29: 66-83. 12. Mehmood Y, Shahid H, Ahmed S, Khursheed A, Jamshaid T, Jamshaid M, et al. Synthesis of vitamin D3 loaded ethosomes gel to cure chronic immune-mediated inflammatory skin disease: Physical characterization, in vitro and ex vivo studies. Sci Rep 2024; 14: 23866-23867. 13. Nasr AM, Moftah F, Abourehab MA, Gad S. Design, formulation, and characterization of valsartan nanoethosomes for improving their bioavailability. Pharmaceutics 2022; 14: 2268-2293. 14. Hameed HI, Al-Mayahy MH. Combined approach of nanoemulgel and microneedle pre-treatment as a topical anticellulite therapy. ADMET DMPK 2024; 12: 903-923. 15. Nasri S, Ebrahimi-Hosseinzadeh B, Rahaie M, Hatamian-Zarmi A, Sahraeian R. Thymoquinone-loaded ethosome with breast cancer potential: Optimization, in vitro and biological assessment. J Nanostruct Chem 2020; 10: 19-31. 16. Sneh P, Jyothi D, James JP, Maxwell A. Formulation and optimization of ethosomes loaded with ropinirole hydrochloride: Application of quality by design approach. Res J Pharm Technol 2020; 13: 4339-4345. 17. Mahmood HS, Alaayedi M, Ghareeb MM, Ali MMM. The enhancement solubility of oral flurbiprofen by using nanoemelsion as drug delivery system. Int J Pharm Res 2020; 12: 1612-1619. 18. Avasarala H, Dinakaran S, Boddeda B, Dasari SP, Jayanthi VR, Swaroopa P. Ethosomal gel: a novel choice for topical delivery of the antipsychotic drug Ziprasidone Hydrochloride. Braz J Pharm Sci 2022; 58: e19317. 19. Al-Ameri AAF, Al-Gawhari FJ. Formulation development of meloxicam binary ethosomal hydrogel for topical delivery: In vitro and in vivo assessment. Pharmaceutics 2024; 16: 898-917. 20. ALaayedi M, Saeed A, Mahmood HS. Improving prochlorperazine profile by formulating the drug as nanoemulsion delivery system. Int J Pharm Res 2020; 6: 2688-2701. 21. Mohamed JMM, Khan BA, Rajendran V, El-Sherbiny M, Othman G, Hussamuldin ABA, et al. Polymeric ethosomal gel loaded with nimodipine: Optimisation, pharmacokinetic and histopathological analysis. Saudi Pharm J 2022; 30: 1603-1611. 22. Mamatha J, Gadili S, Pallavi K. Formulation and evaluation of zidovudine transdermal patch using permeation enhancers. J Young Pharm 2020; 12: s45-50. 23. Hameed GS, Mohamed MBM, Sahib MN. Binary or ternary mixture of solid dispersion: Meloxicam case. Pharmacia 2022; 69: 801-808. 24. Hatem AQ, Ali WK. Preparation and characterization of carvedilol solid dispersion by kneading method. Al Mustansiriyah J Pharm Sci 2023; 23: 367-377. 25. Martihandini N, Surini S, Bahtiar A. Andrographolide-loaded ethosomal gel for transdermal application: Formulation and in vitro penetration study. Pharm Sci 2021; 28: 470-480. 26. Akhtar N, Pathak K. Cavamax W7 composite ethosomal gel of clotrimazole for improved topical delivery: Development and comparison with ethosomal gel. AAPS PharmSciTech 2012; 13: 344-355. 27. Paiva-Santos AC, Silva AL, Guerra C, Peixoto D, Pereira-Silva M, Zeinali M, et al. Ethosomes as nanocarriers for the development of skin delivery formulations. Pharm Res 2021; 38: 947-970. 28. Khan HMS, Tanveer N, Arshad T, Rasool F, Uddin MN, Kazi M. Encapsulation of alpha arbutin, a depigmenting agent, in nanosized ethosomes: In vitro and in vivo human studies. Heliyon 2023; 9: e19326-19340. 29. Akhtar N, Akhtar N, Menaa F, Alharbi W, Alaryani FSS, Alqahtani AM, et al. Fabrication of ethosomes containing tocopherol acetate to enhance transdermal permeation: In vitro and ex vivo characterizations. Gels 2022; 8: 335-357. 30. Zhou Y, Wei YH, Zhang GQ, Wu XA. Synergistic penetration of ethosomes and lipophilic prodrug on the transdermal delivery of acyclovir. Arch Pharm Res 2010; 33: 567-574. 31. Wu J, Xu R, Xu X, Ye S, Huang A. Preparation and evaluation of transdermal permeation of huperzine a ethosomes gel in vitro. BMC Pharmacol Toxicol 2024; 25: 21-29. 32. Ghareeb MM, Mohammed MS. Topical nanoemulsion-based gel of isoconazole nitrate. Al Mustansiriyah J Pharm Sci 2023; 23: 378-396. 33. Sallustio V. Design and characterization of an ethosomal gel encapsulating rosehip extract. Gels 2023; 9: 362-381. 34. Iizhar SA, Syed IA, Satar R, Ansari SA. In vitro assessment of pharmaceutical potential of ethosomes entrapped with terbinafine hydrochloride. J Adv Res 2016 ; 7: 453-461. 35. Faisal W, Soliman GM, Hamdan AM. Enhanced skin deposition and delivery of voriconazole using ethosomal preparations. J Liposome Res 2018; 28: 14-21. 36. Soba SV, Babu M, Panonnummal R. Ethosomal gel formulation of alpha phellandrene for the transdermal delivery in gout. Adv Pharm Bull 2021; 11: 137-149. 37. Aljohani AA, Alanazi MA, Munahhi LA, Hamroon JD, Mortagi Y, Qushawy M, et al. Binary ethosomes for the enhanced topical delivery and antifungal efficacy of ketoconazole. OpenNano 2023; 11: 100145. 38. Sayed OM, Abo El-Ela FI, Kharshoum RM, Salem HF. Treatment of basal cell carcinoma via binary ethosomes of vismodegib: In vitro and in vivo studies. AAPS PharmSciTech 2020; 21: 51. 39. Fathalla D, Youssef EM, Soliman GM. Liposomal and ethosomal gels for the topical delivery of anthralin: Preparation, comparative evaluation and clinical assessment in psoriatic patients. Pharmaceutics 2020; 12: 446-470. 40. Abdallah MH, Lila ASA, Unissa R, Elsewedy HS, Elghamry HA, Soliman MS. Brucine-loaded ethosomal gel: Design, optimization, and anti-inflammatory activity. AAPS PharmSciTech 2021; 22: 269. 41. Priya S, Shridhar P, Shekhara K, Shenthar S, Kudva SK. Tolnaftate-loaded ethosomal gel for topical delivery: Formulation and in vitro evaluation. Health Allied SciNU 2025; 15: 26-31. 42. Limsuwan T, Boonme P, Khongkow P, Amnuaikit T. Ethosomes of phenylethyl resorcinol as vesicular delivery system for skin lightening applications. Biomed Res Int 2017; 2017: 8310979-8310991. 43. Zafar A, Yasir M, Khalid M. Development of piperine-loaded soft binary ethosomal gel to improve transdermal delivery: Box-bhekhen design optimization, ex-vivo permeation, and antimicrobial evaluation. J Clust Sci 2024; 35: 311-325. 44. Inoue D, Yamashita A, To H. Formulation and in vitro characterization of a vacuum-dried drug–polymer thin film for intranasal application. Polymers (Basel) 2022; 14: 2954-2968. 45. Mousa IA, Hammady TM, Gad S, Zaitone SA, El-Sherbiny M, Sayed OM. Formulation and characterization of metformin-loaded ethosomes for topical application to experimentally induced skin cancer in mice. Pharmaceuticals (Basel) 2022; 15: 657-683. 46. Choi S-H, Kim S-Y, Ryoo JJ, Lee K-P. Complexation of the non-steroidal anti-inflammatory drug loxoprofen with modified and unmodified β-cyclodextrins. J Incl Phenom Macrocycl Chem 2001; 40: 139-146. 47. Saadallah MN, Almajidi YQ, Ali A. Binary ethosomal gel for enhanced transdermal delivery of tazarotene: Development, refinement, in vitro evaluation, and skin penetration investigations. Al-Rafidain J Med Sci 2023; 5: S42-50. 48. Hidayah N. The effect of papain enzyme dosage on the modification of egg yolk lecithin emulsifier product through enzymatic hydrolsis reaction. Int J Technol 2018; 9: 380-389. 49. Nasri S, Rahaie M, Ebrahimi-Hoseinzadeh B, Hatamian-Zarmi A, Sahraeian R. A new ethosomal nanoparticle for controlled release of black cumin compounds against cancer cells. Nanomed Res J 2021; 6: 158-169. 50. Nugrahani HN. Stability study of azelaic acid proethosomes with lyoprotectant as stabilizer. J Adv Pharm Technol Res 2018; 9: 61-64. | ||
|
آمار تعداد مشاهده مقاله: 962 تعداد دریافت فایل اصل مقاله: 266 |
||